======= SRSF1 =======
== Gene Information ==
* **Official Symbol**: SRSF1
* **Official Name**: serine and arginine rich splicing factor 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6426|6426]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q07955|Q07955]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SRSF1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SRSF1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600812|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'- CGAGGCG-3' motif in vitro. Three copies of the octamer constitute a powerful splicing enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can specifically activate ASE-dependent splicing. Isoform ASF-2 and isoform ASF-3 act as splicing repressors. May function as export adapter involved in mRNA nuclear export through the TAP/NXF1 pathway. {ECO:0000269|PubMed:8139654}.
|RRM 1|
|DNA topoisomerase binding|
|mRNA 5-splice site recognition|
|alternative mRNA splicing, via spliceosome|
|exon-exon junction complex|
|mRNA splice site selection|
|mRNA cis splicing, via spliceosome|
|spliceosomal complex assembly|
|regulation of alternative mRNA splicing, via spliceosome|
|mRNA 3-end processing|
|catalytic step 2 spliceosome|
|regulation of mRNA splicing, via spliceosome|
|mRNA export from nucleus|
|mRNA-containing ribonucleoprotein complex export from nucleus|
|ribonucleoprotein complex export from nucleus|
|ribonucleoprotein complex localization|
|RNA export from nucleus|
|RNA 3-end processing|
|regulation of RNA splicing|
|regulation of mRNA processing|
|protein export from nucleus|
|mRNA transport|
|nuclear export|
|mRNA binding|
|nucleic acid transport|
|RNA transport|
|establishment of RNA localization|
|RNA localization|
|ribonucleoprotein complex assembly|
|nucleobase-containing compound transport|
|ribonucleoprotein complex subunit organization|
|protein-containing complex localization|
|nucleocytoplasmic transport|
|nuclear transport|
|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|
|mRNA splicing, via spliceosome|
|RNA splicing, via transesterification reactions|
|regulation of mRNA metabolic process|
|RNA splicing|
|nuclear speck|
|ribonucleoprotein complex biogenesis|
|mRNA processing|
|mRNA metabolic process|
|cellular protein-containing complex assembly|
|RNA processing|
|intracellular protein transport|
|RNA binding|
|protein transport|
|intracellular transport|
|peptide transport|
|protein-containing complex assembly|
|amide transport|
|cellular protein localization|
|cellular macromolecule localization|
|establishment of protein localization|
|RNA metabolic process|
|establishment of localization in cell|
|nitrogen compound transport|
|protein-containing complex subunit organization|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp459|Bleomycin 5μM R08 exp459]]|-1.71|
|[[:results:exp530|Thioridazine 5μM R08 exp530]]|1.75|
|[[:results:exp422|Wiskostatin 3μM R07 exp422]]|1.8|
|[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.81|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.508|
|[[:human genes:c:c14orf93|C14orf93]]|0.443|
|[[:human genes:c:cdc73|CDC73]]|0.436|
|[[:human genes:p:ppie|PPIE]]|0.422|
|[[:human genes:i:iscu|ISCU]]|0.419|
|[[:human genes:p:psmb1|PSMB1]]|0.416|
|[[:human genes:p:psmb3|PSMB3]]|0.412|
|[[:human genes:r:rad21|RAD21]]|0.41|
|[[:human genes:n:nup85|NUP85]]|0.405|
|[[:human genes:p:psmd1|PSMD1]]|0.405|
|[[:human genes:d:dnm2|DNM2]]|0.401|
Global Fraction of Cell Lines Where Essential: 534/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|0/1|
|bile duct|22/28|
|blood|24/28|
|bone|17/25|
|breast|26/33|
|central nervous system|42/56|
|cervix|3/4|
|colorectal|12/17|
|esophagus|9/13|
|fibroblast|1/1|
|gastric|9/15|
|kidney|12/21|
|liver|14/20|
|lung|49/75|
|lymphocyte|13/14|
|ovary|18/26|
|pancreas|16/24|
|peripheral nervous system|10/16|
|plasma cell|14/15|
|prostate|1/1|
|skin|13/24|
|soft tissue|5/7|
|thyroid|2/2|
|upper aerodigestive|18/22|
|urinary tract|21/29|
|uterus|3/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 29
* **Expression level (log2 read counts)**: 9.16
{{:chemogenomics:nalm6 dist.png?nolink |}}